HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heather Horne Selected Research

veltuzumab

11/2016Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia.
1/2016Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia.
9/2013Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.
4/2011Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphoma.
7/2009Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heather Horne Research Topics

Disease

5Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2011 - 07/2005
4Neoplasms (Cancer)
06/2011 - 07/2005
3Pancreatic Neoplasms (Pancreatic Cancer)
09/2015 - 06/2011
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2016 - 09/2013
2Adenocarcinoma
09/2015 - 06/2011
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2009 - 08/2005
2Lymphoma (Lymphomas)
07/2009 - 07/2005
2B-Cell Lymphoma (Lymphoma, B Cell)
08/2005 - 07/2005
1Hemorrhage
11/2016
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2016
1Multiple Myeloma
11/2013
1Pancreatic Ductal Carcinoma
11/2012
1Neutropenia
06/2011
1Thrombocytopenia (Thrombopenia)
06/2011
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2009

Drug/Important Bio-Agent (IBA)

5veltuzumabIBA
11/2016 - 07/2009
4Monoclonal AntibodiesIBA
11/2013 - 07/2005
31,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
09/2015 - 07/2005
2GemcitabineFDA Link
09/2015 - 11/2012
2MucinsIBA
09/2015 - 06/2011
2Rituximab (Mabthera)FDA Link
07/2009 - 08/2005
2epratuzumabIBA
08/2005 - 07/2005
1YttriumIBA
09/2015
1milatuzumabIBA
11/2013
1Immunoglobulins (Immunoglobulin)IBA
09/2013
1SteroidsIBA
09/2013
1Inosine Triphosphate (ITP)IBA
09/2013
1clivatuzumabIBA
11/2012
1Glycoproteins (Glycoprotein)IBA
06/2011
1Pharmaceutical PreparationsIBA
06/2011
1AntibodiesIBA
04/2011
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2009
1ORALIT (ORS)IBA
07/2009
1Radioisotopes (Radionuclides)IBA
07/2005
1Proteins (Proteins, Gene)FDA Link
07/2005

Therapy/Procedure

5Therapeutics
11/2016 - 08/2005
5Radioimmunotherapy
09/2015 - 07/2005
3Subcutaneous Injections
11/2016 - 04/2011
1Injections
01/2016
1Immunotherapy
11/2013